The rise of mental health awareness, coupled with rapid technological advancements, is transforming mental health treatment. Submission strategies for clinical trials involving medical devices and in vitro diagnostic devices. A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation. Early phase challenges for biotechs Read the whitepaper. Digital Disruption Surveying the industry's evolving landscape Read the whitepaper.
De-risking clinical development of precision medicines in oncology Read the whitepaper. A multifaceted risk factor: Addressing obesity's impact across the disease spectrum Considerations for clinical trial design focused on obesity treatments. Clinical strategies to optimise SaMD for treating mental health The rise of mental health awareness, coupled with rapid technological advancements, is transforming mental health treatment. Embracing a blended operating model Maximising efficiency and flexibility with custom outsourcing.
Featured Solutions. Blended solutions Bespoke, seamless solutions to meet unique sponsor challenges. Outcome Measures A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients. Biotech ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
Early Clinical and Bioanalytical Solutions Innovative early clinical solutions that will advance your drug development strategy. Market Access Expertise in mission-critical pricing, market access, and reimbursement.
